(NASDAQ:GTX),(NYSE:TT), DAVIDSON, N.C. and PLYMOUTH, Mich. and ROLLE, Switzerland, Feb. 02, 2026 (GLOBE NEWSWIRE) — Trane(R) – by Trane Technologies (NYSE: TT), a global climate innovator, and Garrett Motion (Nasdaq: GTX), a global leader in differentiated turbocharging and electrification technologies, today announced a strategic collaboration to accelerate next generation, oil-free centrifugal compressor technology for commercial […]

Mount Sinai and BPGbio scientists uncover novel molecular drivers from live brain samples that direct human brain structure and function from early development through aging: Creates a completely new molecular understanding of live aging human brain Reveals cellular senescence as a key component of brain structure and degeneration Marks a new era for precision therapies

(NASDAQ:SWVL), DUBAI, United Arab Emirates, Feb. 02, 2026 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), the leading provider of technology-enabled mass mobility solutions, today announced the signing of a new five-year contract (the “Contract”) valued at up to $5.5 million in the United Arab Emirates (“UAE”), further strengthening its position

Seasonal designs highlight stylish bedroom pieces and thoughtful home accents for meaningful gifting LAS ANGELES, Feb. 02, 2026 (GLOBE NEWSWIRE) — Homary today announced the launch of its Valentine's Day furniture gift collection, offering a curated selection of stylish and functional home pieces designed to help couples celebrate romance through thoughtful interior upgrades. The seasonal

(NasdaqGM:SKYE), 22.3% total weight loss at 52 weeks with nimacimab (200 mg dose) + semaglutide (2.4 mg) combination — no plateau observed, suggesting potential for further efficacy beyond one year and at higher nimacimab doses Weight regain during treatment interruption reduced by over 50% — nimacimab + semaglutide cohort regained only 17.8% of lost weight

(TSX-V:NEXG),(OTC US:NXGCF),(Other OTC:NXGCF), TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company“) is pleased to provide initial results from the recently announced diamond drilling program (Company news release dated January 28, 2026), which comprises up to 25,000 metres at the Goliath Gold Complex (comprised of the

(NasdaqGM:SGMT), SAN MATEO, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that Ascletis Pharma Inc. issued a press release on January 29th reporting positive topline results in the open-label Phase 3 trial evaluating the long-term safety

(OTCQB:BIXT),(OTC US:BIXT), NEEDHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) — Bioxytran, Inc. (OTCQB: BIXT) (“Bioxytran” or the “Company”), a clinical-stage biotechnology company developing platform technologies spanning glycovirology, hypoxia, and degenerative diseases, announced the execution of a Sponsored Research Agreement with the University of Minnesota to support advanced biochemical research aimed at improving the understanding and

(NASDAQ:TTMI),(NYSE:DCO),(NASDAQ:WWD),(NYSE:CACI), SANTA ANA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ: TTMI), a leading global manufacturer of technology products, including mission systems, radio frequency (“RF”) components and RF microwave/microelectronic assemblies, and technologically advanced interconnect solutions, including printed circuit boards (“PCB”) and substrates, today announced that, after long and distinguished careers with TTM,

(TSX-V:ROCK),(OTC US:TRDTF),(Other OTC:TRDTF), Vancouver, BC, Feb. 02, 2026 (GLOBE NEWSWIRE) — Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company“) is pleased to announce that, in connection with its previously announced bought deal financing (the “Bought Deal Offering“), the underwriters led by Haywood Securities Inc., and including Research Capital Corporation (collectively, the “Underwriters“),